MX337439B - Suspensiones novedosas de nanocristales bimetalicos basados en oro-platino, procedimientos de fabricacion electroquimica para las mismas y sus usos. - Google Patents

Suspensiones novedosas de nanocristales bimetalicos basados en oro-platino, procedimientos de fabricacion electroquimica para las mismas y sus usos.

Info

Publication number
MX337439B
MX337439B MX2013011245A MX2013011245A MX337439B MX 337439 B MX337439 B MX 337439B MX 2013011245 A MX2013011245 A MX 2013011245A MX 2013011245 A MX2013011245 A MX 2013011245A MX 337439 B MX337439 B MX 337439B
Authority
MX
Mexico
Prior art keywords
suspensions
metal
bimetallic
platinum
gold
Prior art date
Application number
MX2013011245A
Other languages
English (en)
Other versions
MX2013011245A (es
Inventor
Mark G Mortenson
David A Bryce
D Kyle Pierce
Mikhail Merzliakov
Adam R Dorfman
Maxwell A Grace
Original Assignee
Gr Intellectual Reserve Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gr Intellectual Reserve Llc filed Critical Gr Intellectual Reserve Llc
Publication of MX2013011245A publication Critical patent/MX2013011245A/es
Publication of MX337439B publication Critical patent/MX337439B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/242Gold; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/243Platinum; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1611Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82BNANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
    • B82B1/00Nanostructures formed by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82BNANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
    • B82B3/00Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
    • B82B3/0009Forming specific nanostructures
    • CCHEMISTRY; METALLURGY
    • C22METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22CALLOYS
    • C22C30/00Alloys containing less than 50% by weight of each constituent
    • CCHEMISTRY; METALLURGY
    • C22METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22CALLOYS
    • C22C5/00Alloys based on noble metals
    • C22C5/02Alloys based on gold
    • CCHEMISTRY; METALLURGY
    • C22METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22CALLOYS
    • C22C5/00Alloys based on noble metals
    • C22C5/04Alloys based on a platinum group metal
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Metallurgy (AREA)
  • Mechanical Engineering (AREA)
  • Materials Engineering (AREA)
  • Nanotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Manufacturing & Machinery (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Manufacture Of Metal Powder And Suspensions Thereof (AREA)
  • Powder Metallurgy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Catalysts (AREA)

Abstract

La presente invención se refiere a suspensiones de nanocristal bimetálico con base en oro-platino novedosas que tienen superficies de nanocristal que sustancialmente están libres de impurezas orgánicas u otras o películas asociadas con reductores/estabilizadores químicos típicos y/o materias primas utilizadas en los procesos de formación de nanopartículas; específicamente, las superficies son "limpias" en relación a las superficies de nanopartículas basadas en metal hechas mediante los procesos reducción química (y otros) que requieren reductores orgánicos (u otros) y/o agentes tensoactivos para crecer (y/o suspender) nanopartículas de metal de iones metálicos en una solución; la invención incluye aparatos y técnicas de fabricación electroquímica novedosos para la fabricación de las suspensiones de nanocristal bimetálico; las técnicas no requieren el uso o la presencia de iones/átomos de cloro y/o cloruros o materiales a base de cloro para el proceso de fabricación/suspensión final; la invención además incluye composiciones farmacéuticas de las mismas y el uso de los nanocristales bimetálicos o suspensiones o coloides de los mismos para el tratamiento o la prevención de enfermedades o condiciones para las cuales la terapia basada en metal ya es conocida, incluyendo, por ejemplo, para las enfermedades o condiciones cancerosas. 31 B.
MX2013011245A 2011-03-30 2012-03-30 Suspensiones novedosas de nanocristales bimetalicos basados en oro-platino, procedimientos de fabricacion electroquimica para las mismas y sus usos. MX337439B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161469525P 2011-03-30 2011-03-30
PCT/US2012/031654 WO2012135743A2 (en) 2011-03-30 2012-03-30 Novel gold-platinum based bi-metallic nanocrystal suspensions, electrochemical manufacturing processes therefor and uses for the same

Publications (2)

Publication Number Publication Date
MX2013011245A MX2013011245A (es) 2013-10-17
MX337439B true MX337439B (es) 2016-03-03

Family

ID=46932416

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013011245A MX337439B (es) 2011-03-30 2012-03-30 Suspensiones novedosas de nanocristales bimetalicos basados en oro-platino, procedimientos de fabricacion electroquimica para las mismas y sus usos.

Country Status (15)

Country Link
US (3) US9387225B2 (es)
EP (1) EP2691082B1 (es)
JP (1) JP6121985B2 (es)
KR (2) KR101955735B1 (es)
CN (1) CN103764123B (es)
BR (1) BR112013025112A2 (es)
CA (1) CA2829095C (es)
DK (1) DK2691082T3 (es)
ES (1) ES2564672T3 (es)
IL (1) IL228356A (es)
MX (1) MX337439B (es)
PH (1) PH12013501954A1 (es)
RU (1) RU2617055C2 (es)
SG (1) SG193439A1 (es)
WO (1) WO2012135743A2 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009009143A1 (en) * 2007-07-11 2009-01-15 Gr Intellectual Reserve, Llc Continuous methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) resulting therefrom
EP2735389A1 (de) * 2012-11-23 2014-05-28 Universität Duisburg-Essen Verfahren zur Herstellung reiner, insbesondere kohlenstofffreier Nanopartikel
JP5891320B1 (ja) * 2015-02-12 2016-03-22 秋田県 ゼータ電位制御法を用いた処理方法
CN106680450B (zh) * 2017-03-23 2023-04-25 江西省农业科学院农业经济与信息研究所 水质监测装置及方法
US11674234B1 (en) * 2020-09-30 2023-06-13 National Technology & Engineering Solutions Of Sandia, Llc Electrodeposited platinum-gold alloy
CN112683710B (zh) * 2020-12-02 2024-04-16 大连理工大学 一种氯离子侵蚀下钢筋混凝土桥板加速腐蚀的试验装置
CN112935273A (zh) * 2021-01-26 2021-06-11 哈尔滨理工大学 一种室温制备CuPt合金纳米颗粒的方法
JP2022131579A (ja) 2021-02-26 2022-09-07 キオクシア株式会社 分析装置および分析方法
CN113500199B (zh) * 2021-06-10 2022-11-08 浙江大学 一种基于金铂双金属活性氧自生成纳米材料的制备方法及其产品和应用
CN113777034B (zh) * 2021-08-20 2024-04-19 嘉兴学院 金纳米双锥阵列基底及其制备方法和应用
CN114470201B (zh) * 2021-12-24 2024-03-19 上海市儿童医院 一种装载kcna5抗体的金铂纳米颗粒及其制备方法和应用
CN120504491B (zh) * 2025-07-21 2025-09-16 景德镇学院 一种稳定陶瓷釉料烧制发色的添加剂及其方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2343047B2 (en) * 2000-02-08 2021-03-17 Rice University Optically-active nanoparticles for use in therapeutic and diagnostic methods
US7001617B2 (en) * 2001-04-23 2006-02-21 Nueryst Pharmaceuticals Corp. Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals
US6989157B2 (en) 2000-07-27 2006-01-24 Nucryst Pharmaceuticals Corp. Dry powders of metal-containing compounds
JP2002212102A (ja) * 2001-01-23 2002-07-31 Ainobekkusu Kk 電気化学的生理活性微粒子
WO2002085387A2 (en) * 2001-04-23 2002-10-31 Nucryst Pharmaceuticals Corp. A medicament or a dressing containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent ans their use in the treatment of inflammatory skin conditions
US20080190770A1 (en) * 2004-04-26 2008-08-14 Cap Technologies, Llc Treatment of Fluids and/or Sludge with Electro Plasma
TW200704404A (en) * 2005-03-23 2007-02-01 Shetech Co Ltd Precious metal nanocolloid solution
WO2007079452A2 (en) * 2006-01-03 2007-07-12 Gr Intellectual Reserve, Llc Methods and apparatuses for making liquids more reactive
KR100857389B1 (ko) * 2006-06-30 2008-09-11 (주)아모레퍼시픽 Ap-grr 펩티드 또는 ap-grr 펩티드를 포함하는펩티드사슬 및 이를 포함하는 약물전달담체
TW200819540A (en) 2006-07-11 2008-05-01 Genelux Corp Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders
WO2009009143A1 (en) 2007-07-11 2009-01-15 Gr Intellectual Reserve, Llc Continuous methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) resulting therefrom
AU2008302035A1 (en) * 2007-09-21 2009-03-26 Cytimmune Sciences, Inc. Nanotherapeutic colloidal metal compositions and methods
US9067263B2 (en) 2009-01-15 2015-06-30 Gr Intellectual Reserve, Llc Continuous, semicontinuous and batch methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) and colloids resulting therefrom
ES2623504T3 (es) * 2009-07-08 2017-07-11 Clene Nanomedicine, Inc. Nanocristales novedosos basados en oro para tratamientos médicos y procedimientos de fabricación electroquímica para los mismos
KR101090431B1 (ko) * 2009-08-19 2011-12-07 삼성전기주식회사 금속 씨앗을 이용한 금속 나노입자의 제조 방법 및 금속 씨앗을 함유하는 금속 나노입자

Also Published As

Publication number Publication date
RU2013148011A (ru) 2015-05-10
SG193439A1 (en) 2013-10-30
WO2012135743A3 (en) 2014-05-01
KR20140020310A (ko) 2014-02-18
CN103764123B (zh) 2018-03-13
US20140294963A1 (en) 2014-10-02
CN103764123A (zh) 2014-04-30
ES2564672T3 (es) 2016-03-28
EP2691082B1 (en) 2016-01-13
KR101955735B1 (ko) 2019-03-07
EP2691082A2 (en) 2014-02-05
AU2012236213A1 (en) 2013-11-14
CA2829095A1 (en) 2012-10-04
US9387225B2 (en) 2016-07-12
WO2012135743A2 (en) 2012-10-04
DK2691082T3 (en) 2016-02-29
JP6121985B2 (ja) 2017-04-26
RU2617055C2 (ru) 2017-04-19
IL228356A (en) 2017-04-30
PH12013501954A1 (en) 2013-11-25
AU2012236213A2 (en) 2014-01-23
KR102103534B1 (ko) 2020-04-23
MX2013011245A (es) 2013-10-17
US20160317578A1 (en) 2016-11-03
EP2691082A4 (en) 2015-06-24
US20230172975A1 (en) 2023-06-08
NZ617018A (en) 2015-10-30
JP2014518847A (ja) 2014-08-07
CA2829095C (en) 2019-08-27
BR112013025112A2 (pt) 2020-09-29
IL228356A0 (en) 2013-12-31
KR20190027933A (ko) 2019-03-15

Similar Documents

Publication Publication Date Title
MX337439B (es) Suspensiones novedosas de nanocristales bimetalicos basados en oro-platino, procedimientos de fabricacion electroquimica para las mismas y sus usos.
PH12017501884A1 (en) Novel gold-based nanocrystals for medical treatments and electrochemical manufacturing processes therefor
Leo et al. The stability of silver nanoparticles in a model of pulmonary surfactant
MX2016005668A (es) Formas cristalinas de compuestos terapeuticos y sus usos.
WO2014066850A3 (en) Metastable silver nanoparticle composites
MX391741B (es) Composicion farmaceutica para prevenir o tratar el cancer de mama que incluye polimorfo cristalino de hexaoxido de tetraarsenico y metodo para preparar el mismo
MX2019005737A (es) Composicion farmaceutica para prevenir o tratar el cancer de cerebro que incluye polimorfocristalino de hexaoxido de tetraarsenico y metodo para preparar el mismo.
MX389813B (es) Composicion de mezcla maestra que comprende una elevada concentracion de entidades biologicas
FR2985274B1 (fr) Structures fibreuses comprenant des particules et leur procede de fabrication
EP3466882A4 (en) METHOD FOR PRODUCING SILICONE COMPOUND COATED OXIDE PARTICLES, SILICONE COMPOUND COATED OXIDE PARTICLES, AND SILICONE COMPOUND COATED OXID COMPOSITION THEREWITH
EP4495059A3 (en) Silicon nanoparticles for use in treating kidney diseases
EP2706597A4 (en) SURFACE TREATMENT METHOD FOR ANODE-ACTIVE MATERIAL PARTICLES AND ANODE-ACTIVE MATERIAL PARTICLES MOLDED IN THIS PROCEDURE
EP4257615A4 (en) SELF-ASSEMBLED NANOPARTICLE CONTAINING EB VIRUS GB PROTEIN, ITS PREPARATION METHOD AND ITS USE
EP3385359A4 (en) DOCOSAHEXAIC ACID-CONTAINING OIL AND METHOD FOR THE PRODUCTION THEREOF
BR112017025631A2 (pt) composições oftálmicas aquosas, método de induzir ou aumentar a formação de lágrima, método de formação de aglomerados de ciclosporina a e uso de ciclosporina a
EA201491691A1 (ru) Агрегаты наночастиц, содержащие остеопонтин и кальций- и/или стронцийсодержащие частицы
AR063825A1 (es) Metodo de tratamiento para telas y composicion para impartir hidrofobicidad diferencial
EP3424877A4 (en) SILVER-CONTAINING CALCIUM PHOSPHATE SINTERED BODY AND METHOD FOR THE PRODUCTION THEREOF
EP2949454A3 (en) Hydrogels and medical devices with pure nano-particles embedded
BR112015004469A2 (pt) sirna e seu uso em métodos e composições para o tratamento e/ou prevenção de condições oculares
MA46235B1 (fr) 1-aryl-naphtyridin-3-ylcarboxamides substitués en position 7 et leur utilisation
EA200801437A1 (ru) Способы производства металлооксидных наночастиц с регулируемыми свойствами и наночастицы и вещества, полученные такими способами
EP3552610A4 (en) INORGANIC COMPOSITION WITH EXCELLENT PROPERTIES FOR THE STEP-BY-STEP RELEASE OF ZINCIONS AND PRODUCTION METHOD THEREFOR
EP3919585A4 (en) Quantum dot-containing nanoparticle and method for manufacturing same
MX2017007018A (es) Nanopartículas para encapsular compuestos, su preparación y sus usos.

Legal Events

Date Code Title Description
FG Grant or registration